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Effect of Sodium Nitroprusside on Ventilation-Perfusion Mismatching
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San Diego, California
Sodium nitroprusside has been shown to lower arterial
partial pressure of oxygen (Paoj) in patients with conges-
tive heart failure and respiratory failure. The multiple
inert gas elimination technique was used to evaluate the
effect of sodium nitroprusside infusion on pulmonary
gas exchange in five patients with congestive heart fail-
ure. During sodium nitroprusside infusion, mean values
of cardiac output increased and mean values of arterial
pressure, pulmonary artery pressure, pulmonary artery
wedge pressure and pulmonary vascular resistance de-
creased. Cardiac output increased in each patient and
Pao, decreased in all but one patient (mean 75.6 ± 15.1
to 68 ± 17.5 mm Hg, p =0.032).
Distributions of ventilation and perfusion showed in-
creased perfusion of lung units with low (s 0.1) venti-
lation-perfusion ratios in all subjects during sodium ni-
troprusside infusion(mean 3.89 ± 1.52 to 11.33 ± 7.42%
Since 1929, sodium nitroprusside has been known to lower
blood pressure (I), although it has been used to treat hy-
pertension only since 1955 (2). Because no direct cardiac
or nervous system effects have been demonstrated, it is
thought to be a "pure" vasodilator. Because it lowers left
ventricular afterload, it has also been widely used in recent
years to treat left ventricular failure (3). Although sodium
nitroprusside infusion results in increased cardiac output in
patients with heart failure (4-6), it has also been shown to
decrease arterial partial pressure of oxygen (Pao-) in both
human subjects (4-9) and animals (10-12), although most
uniformly in patients with congestive heart failure and res-
piratory failure (9). The decrease in Pao, has been attributed
to increased ventilation-perfusion inequality in the lung
(4,6,7,13). However this has never been directly demon-
strated to be the case in human subjects, and sodium nitro-
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of cardiac output, p =0.027, paired t test). The amount
of shunt (fractional perfusion of lung units with venti-
lation-perfusion ratio =0) increased in the two patients
with some shunt present in the baseline measurements.
The mean total low ventilation-perfusion perfusion (shunt
plus ventilation-perfusion s 0.1) was significantly in-
creased from 4.38 ± 1.54 to 14.7 ± 9.37% (p = 0.023)
during sodium nitroprusside infusion. Total low venti-
lation-perfusion perfusion was negatively correlated with
mean pulmonary artery pressure and pulmonary artery
wedgepressure (r = - 0.949 and - 0.946, respectively).
Although sodium nitroprusside infusion increased
cardiac output and overall oxygen transport in all pa-
tients, it worsened ventilation-perfusion mismatching.
The mechanism is probably pulmonary vasodilation or
increased cardiac output, or both.
prusside might alter pulmonary gas exchange through other
mechanisms.
To define how Pao, is determined by these multiple op-
posing factors requires a direct method of evaluating ven-
tilation-perfusion mismatching, such as the multiple inert
gas elimination technique by which one can estimate dis-
tributions of ventilation and perfusion as a function of ven-
tilation-perfusion ratio (14) without using metabolized gases.
Studies (12) utilizing the multiple inert gas elimination tech-
nique in dogs with and without oleic acid-induced pulmo-
nary edema showed that only those with pulmonary edema
had increased perfusion of lung units with low ventilation-
perfusion ratios during infusion of sodium nitroprusside.
Ventilation-perfusion relations have not been studied in
human subjects given sodium nitroprusside using the mul-
tiple inert gas elimination technique. Therefore, to deter-
mine the effect of sodium nitroprusside on ventilation-per-
fusion mismatching itself rather than just the well studied
effect on Pao-, we used the multiple inert gas elimination
technique to measure distributions of ventilation and per-
fusion before and during infusion of sodium nitroprusside
in five patients with chronic congestive heart failure.
0735-1097/84/$3.00
lACC Vol. 4. No.5
November1984:918-22
BENCOWITZ ET AL.
SODIUM NITROPRUSSIDE AND VENTILATION·PERFUSION MISMATCHING
919
Methods
Study patients. We studied five men, each of whom
had chronic congestive heart failure due to ischemic heart
disease documented by prior acute myocardial infarction or
cardiac catheterization and coronary arteriography, or both.
Each patient was receiving digitalis and diuretic drugs. No
medication was discontinued for this study. The men, whose
ages ranged from 56 to 78 years, were all patients at the
San Diego Veterans Administration Medical Center and each
signed a consent form approved by the University of Cal-
ifornia-San Diego Committee on Investigations Involving
Human Subjects. Each underwent right heart catheterization
and short-term sodium nitroprusside infusion to evaluate his
suitability for long-term oral vasodilator therapy.
Methodology. The patients were studied in the coronary
care unit or cardiac catheterization laboratory. In each pa-
tient we placed percutaneously: I) a peripheral intravenous
cannula for infusion of a solution containing trace amounts
of six inert gases for the multiple inert gas elimination tech-
nique; 2) a brachial or radial arterial cannula for blood
sampling and monitoring of arterial pressure; and 3) a bal-
loon-tipped flow-directed pulmonary artery catheter for
sampling and measurement of pulmonary artery pressure
and pulmonary artery wedge pressure. This catheter was
equipped with a thermistor for measurement of cardiac out-
put by the thermodilution technique.
Measurements. Intravascular pressures were measured
with a Statham P23Db transducer coupled to appropriate
amplifiers. The zero reference level was at the mid chest.
Pressures reported in this study were electronically obtained
mean values. Cardiac output by the thermodilution tech-
nique was calculated with a dedicated computer (American
Edwards Laboratories model 9520A) after injection of 10
ml of room temperature 5% dextrose in water through the
proximal port of the balloon-tipped catheter. Pulmonary
vascular resistance (dynes-s-cm- 5) was calculated as (Ppa
- Ppaw) X 80 -:- CO, where Ppa == mean pulmonary
artery pressure, Ppaw = mean pulmonary artery wedge
pressure and CO = cardiac output (liters/min). Three mil-
liliter samples of arterial and pulmonary arterial blood were
withdrawn slowly over I minute, placed in ice immediately
and blood gases measured within I hour (813 pH/blood gas
analyzer, Instrumentation Laboratory). In one patient (Case
3), pulmonary artery samples collected for measurement of
blood gases during sodium nitroprusside infusion were clot-
ted and the values were estimated from the ventilation-
perfusion distributions (15).
Oxygen consumption was calculatedusing the Fickprin-
ciple: oxygen consumption (mllmin) == CO x 10 x (ar-
terial content - mixed venous content), where oxygen con-
tents are expressed as ml oxygen/IOO ml blood. Total oxygen
transport (ml of oxygen per minute) was calculated as: O2
trans == 10 x CO x arterial O2content, where hemoglobin
concentration and saturation were calculated from the mea-
sured hematocrit (hemoglobin == hematocrit -:- 3) and blood
gases, respectively, (oxygen content == 1.39 x hemoglobin
x percent oxygen saturation -:- 1(0).
Estimation of ventilation-perfusion distribution. Ten
milliliter samples of arterial and pulmonary artery blood
were also collected for estimation of ventilation-perfusion
distribution by the multiple inert gas elimination technique.
Samples of mixed expired gas were collected by having the
subject breath through a mouthpiece attached to a nome-
breathing valve connected to a heated mixing box. The
patient was instructed to relax and avoid changes in respi-
ratory pattern (tidal volume and frequency). Distributions
of ventilation and perfusion were estimated from these sam-
ples as previously described (14). On the basis of the re-
sulting distributions, we defined shunt as the fraction of
total blood flow perfusing functional lung units with a ven-
tilation-perfusion ratio equal to zero, blood flow in low
ventilation-perfusion regions as the fraction of cardiac out-
put perfusing lung units with ventilation-perfusion ratios of
0.1 or less and total low ventilation-perfusion unit perfusion
as the sum of shunt and blood flow of low ventilation-
perfusion units.
Protocol. Duplicate sets of blood and expired gas sam-
ples were collected in each patient under baseline conditions
and during infusion of sodium nitroprusside. Pressures and
cardiac output were measured immediately after collection
of the samples. Before the samples were collected under
each condition, the inert gas solution was infused for at least
30 minutes while the patient breathed through a mouthpiece
and pulmonary artery pressure, arterial pressure and breath-
ing pattern were stable.
Sodium nitroprusside infusion. After baseline samples
had been collected, a fresh solution of sodium nitroprusside
(100 iLg/ml) was infused by a constant rate infusion pump
(IVAC Corporation). The rate of the infusion was adjusted
to achieve a primary end point of reducing the pulmonary
artery wedge pressure to 15 to 20 mm Hg, providing the
mean arterial pressure did not decrease by more than 10
mm Hg. If the latter occurred and was tolerated well, this
was taken as the end point of sodium nitroprusside infusion.
Once these end points were reached, the infusion was main-
tained at constant rate for at least 20 minutes before samples
were obtained. Infusion rates ranged from 0.5 to 2.79 iLg/kg
per min. The sodium nitroprusside infusion was discontin-
ued as soon as samples had been collected. No adverse
effects were encountered in any of the patients.
Statistical analysis. Results obtained before and during
sodium nitroprusside infusion were compared using one-
tailed paired t tests since we had strong expectations that
sodium nitroprusside would increase cardiac output, venous
partial pressure of oxygen (PV02) and ventilation-perfusion
mismatching, but would decrease pressures and Pao-. Data
shown in Table I for individual patients are the mean values
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Table 1. Values Before and During Nitroprusside Infusion
Low Total
CO Part ppa Ppaw PYR Paoz Pvoz Shunt YA/O Low OzTrans
Case B D B D B D B D B D B D B D B D B D B D B D
I 3.3 3.8 80 78 33 25 21 14 291 232 59 50 33 29 0,55 4.5 5.9 22.1 6.5 26.6 630 652
2 3.2 4.2 66 60 34 31 22 19 299 226 82 83 29 34 0.0 0.0 4.8 15.9 4.8 15.9 613 791
3 2.4 6.6 63 56 32 28 23 20 298 97 70 53 25 36 1.9 12.5 2.7 8.0 4.6 20.5 443 1,140
4 3.8 4.2 80 69 52 40 35 24 357 305 99 89 30 35 0.0 0.0 3.9 4.45 3.9 4.45 634 693
5 2.8 5.0 83 72 48 45 34 24 394 335 69 66 29 33 0.0 0.0 2.2 6.25 2.2 6.25 467 750
Mean 3.1 4.8 74 67 40 34 27 20 327 239 76 68 29 33 0.49 2.9 3.9 11.3 4.4 14.7 557 805
± SD 0.52 I.I 9.2 8.9 9.4 8.4 6.9 4.1 45.8 92.1 15 17 2.3 2.7 0.82 4.6 1.5 7.42 1.5 9.37 94.1 195
P 0.04 0.01 0.01 0.01 0.02 0.03 0.04 0.12 0.Q3 0.02 0.06
p values are derived from one-tailed paired t tests. B = before nitroprusside infusion; CO = cardiac output (liters/min); D = during nitroprusside
infusion; Low YAlO = fractional perfusion of lung units with ventilation-perfusion ratio of O.I or less (%); OzTrans = total oxygen transport (ml of
oxygen/min); Part, Ppa and Ppaw = systemic arterial, pulmonary artery and pulmonary artery wedge pressures, respectively (mm Hg); Pao, and Pvoz
= arterial Paz and mixed venous POz, respectively (mm Hg); PYR = pulmonary vascular resistance (dynes-s-cm r "); Shunt = fractional perfusion of
lung units with ventilation-perfusion ratio equal to 0; Total low = shunt + Low YAlO (%).
(± standard deviation) of three measurements for cardiac
output and the mean values of two measurements for Paoz,
Pvoz, shunt, low ventilation-perfusion perfusion, total low
ventilation-perfusion perfusion and total oxygen transport.
Mean results were considered significantly different at the
probability level of :5 0.05.
Results
Hemodynamic response. Sodium nitroprusside infu-
sion was associated with an increase in mean cardiac output
from 3.12 ± 0.52 to 4.78 ± 1.121iters/min (p = 0.040)
and decreases in mean arterial pressure (from 74.4 ± 9.2
to 67.0 ± 8,9 mm Hg; p = 0.006), mean pulmonary artery
pressure (from 40 ± 9.5 to 34 ± 8.4 mm Hg; p = 0.014),
mean pulmonary artery wedge pressure (from 27 ± 6.9 to
20 ± 4.2 mm Hg; p = 0.008) and mean pulmonary vascular
resistance (from 327 ± 45.8 to 239 ± 92.1 dynes-scm";
p = 0.017). These mean changes were statistically signif-
icant and reflected changes seen in each individual patient.
Blood gases. Pao, decreased in all but one patient (Case
2), in whom it increased insignificantly from 82 to 82.5 mm
Hg. Mean Pao; decreased from 75.6 ± 15.1 to 68.0 ±
17.5 mm Hg (p = 0.032). Mean Pvoz increased from 28.8
± 2.3 to 33.4 ± 2.7 mm Hg (p = 0.045). Pvoz increased
in all but one patient (Case 1). Oxygen consumption did
not change significantly during sodium nitroprusside infu-
sion (mean 221.7 ± 24.5 to 236.0 to 43.4 ml oxygen/min,
p = 0.28).
Ventilation-perfusion distribution. Sodium nitro-
prusside infusion increased the amount of ventilation-per-
fusion mismatching. In all five patients, baseline distribu-
tions of ventilation and perfusion showed a distinct bimodal
distribution with a small fraction (mean 3.89 ± 1.52%) of
total blood flow in lung units associated with a low venti-
lation-perfusion ratio. Only two patients (Cases 1 and 3)
had any shunt and these were very small (0.55 and 1.90%,
respectively). During sodium nitroprusside infusion, the
fraction of cardiac output perfusing lung units with a low
ventilation-perfusion ratio increased in all five patients and
substantially in three of these (Cases 1 to 3). The increase
in mean low ventilation-perfusion perfusion (3.89 ± 1.52
to 11.33 ± 7.42%) was significant (p = 0.027). Shunt
increased in the two patients (Cases 1 and 3) in whom it
was present in baseline measurements (0.55 to 4.5% and
1.9 to 12.45%, respectively). No shunt developed in the
remaining three patients. The increase in mean total low
ventilation-perfusion perfusion (shunt + low ventilation-
perfusion) was significant (4.38 ± 1.54 to 14.7 ± 9.37%,
p = 0.023).
Patients 4 and 5 had a smaller increase in low ventilation-
perfusion perfusion than did the other three patients (Table
I). These two patients were distinguished from the others
by higher values for pulmonary artery pressure, pulmonary
artery wedge pressure and pulmonary vascular resistance
both in baseline measurements and during sodium nitro-
prusside infusion. Total low ventilation-perfusion perfusion
during sodium nitroprusside infusion was negatively cor-
related (r = - 0.9491 and - 0.9462, respectively) with
mean pulmonary artery pressure and mean pulmonary artery
wedge pressure.
Discussion
Comparisonwith previousstudies. Several studies have
shown that sodium nitroprusside infusion leads to lower
arterial partial pressure of oxygen (Pao-) in human subjects
with heart failure (4-6) and respiratory failure (9). In an-
esthetized normal subjects, the reported results (7,8,16-18)
are conflicting, suggesting a variable effect. Almost all stud-
ies (5,12,19-25) in normal animals have failed to demon-
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strate this decrease in Pao-. Mechanisms other than venti-
lation-perfusion mismatching that might change Pao, in-
clude: I) increased cardiac output leading to increased mixed
venous P02 (PV02) and, thus, to increased Pao; if a fixed
amount of ventilation-perfusion mismatching is present; and
2) changes in tissue perfusion leading to changed oxygen
consumption. The only previous study (12) of sodium ni-
troprusside that used the multiple inert gas elimination tech-
nique in dogs demonstrated that dogs studied after oleic
acid-induced pulmonary edema developed decreased Pao;
and increased shunt and perfusion of lung units with low
ventilation-perfusion ratio during infusion of sodium nitro-
prusside. Pao, and ventilation-perfusion matching were not
significantly changed in normal dogs.
In all five of our patients with left ventricular failure,
we found that infusion of sodium nitroprusside is associated
with increased ventilation-perfusion mismatching in the lung,
namely, increased perfusion of functional lung units with
ventilation-perfusion ratios of 0.1 or less. This change was
associated with a decrease in Pao, in all but one patient.
The small amount of perfusion of lung units with low ven-
tilation-perfusion ratio found in the baseline samples was
probably secondary to mild pulmonary edema.
Possible mechanisms of nitroprusside effect. De-
creased pulmonary vascular resistance during infusion of
sodium nitroprusside in human subjects has been reported
in patients with congestive heart failure and adult respiratory
distress syndrome and a group of nine normal subjects
(4,5,6,9) although it was not significantly decreased in five
patients with chronic obstructive pulmonary disease (8),
patients with spontaneous hypertension after coronary artery
bypass surgery (1) and patients after acute myocardial in-
farction (26). Results of animal studies (11,12,25,27,28)
have been inconsistent. We also noted decreased pulmonary
vascular resistance, which suggests that sodium nitroprus-
side had a pulmonary vasodilator effect, although this change
is difficult to interpret in the setting of increased cardiac
output. Moreover, previous work (12,22,28-30) has produced
strong evidence indicating that sodium nitroprusside pre-
vents hypoxic pulmonary vasoconstriction.
Thus, vasodilation (or increased perfusion through in-
direct mechanisms) occurs largely in underventilated areas,
accounting for the increased perfusion of lung units with
low ventilation-perfusion ratio. This concept is supported
by our observation that the two patients (Cases 4 and 5)
with the least increase in perfusion of units with low ven-
tilation-perfusion ratio were those with the least decrease in
pulmonary vascular resistance during sodium nitroprusside
infusion. These patients had higher baseline values of pul-
monary artery pressure and pulmonary vascular resistance
and more "fixed" pulmonary vasculature indicated by less
decrease in pulmonary vascular resistance during sodium
nitroprusside infusion.
However, we also observed significant increases in car-
diac output during sodium nitroprusside infusion, An in-
crease in cardiac output alone has been shown in dogs to
increase fractional perfusion of lung units with low venti-
lation-perfusion ratio in the presence of a bimodal venti-
lation-perfusion distribution in an asthma model (H. Ben-
cowitz, unpublished results). It has also been shown (31,32)
to increase shunt fraction in oleic acid-induced pulmonary
edema. However, the effect of changes in cardiac output on
Pao, is more complicated, because increased PV02 increases
cardiac output and leads to increased Pao, for any given
amount of ventilation-perfusion mismatching. Thus, the net
effect of cardiac output on Pao, is the balance between two
opposing events: increased PV02 and worsened ventilation-
perfusion matching, Therefore, a change in Pao; can not
be used to infer the effect on ventilation-perfusion relations.
This is illustrated by Case 2 in which Pao, remained es-
sentially unchanged during sodium nitroprusside infusion,
although the perfusion of lung units with low ventilation-
perfusion ratio increased substantially. If the cardiac output
had not increased, Pao, would have been lower.
Clinical implications. Although infusion of sodium ni-
troprusside in our patients had a beneficial effect on cardiac
output and overall oxygen transport, it adversely altered the
relation between ventilation and perfusion in the lung. More-
over, many patients in whom sodium nitroprusside therapy
is indicated are hypoxic and it has been shown that sodium
nitroprusside is more detrimental to gas exchange in patients
with heart failure and adult respiratory distress syndrome
than in normal subjects. Therefore, when sodium nitro-
prusside is used or the dosage increased in patients with
heart failure, one should be aware of its potentially dele-
terious effects.
References
I. Flaherty JT, Magee PA, Gardner TL, Potter A, MacAllister NP.
Comparison of intravenous nitroglycerin and sodium nitroprusside for
treatment of acute hypertension developing after coronary artery by-
pass surgery. Circulation 1982;65: 1072-7.
2. Page IH, Corcoran AC, Dustan HP, Koppanyi T. Cardiovascular
actions of sodium nitroprusside in animals and hypertensive patients.
Circulation 1955;11:188-98.
3. Franciosa JA, Guiha NH, Limas CJ, Rodriguera E, Cohn IN. Im-
proved left ventricular function during nitroprusside infusion in acute
myocardial infarction. Lancet 1972;7752:650-4.
4. Mookherjee S, Keighley JFH, Warner RA, Bowser MA, Obeid AI.
Hemodynamic, ventilatory and blood gas changes during infusion of
sodium nitroferricyanide (nitroprusside). Chest 1977;72:273-8.
5. Vrobel TR, Cohn IN. Comparative hemodynamic effects of converting
enzyme inhibitor and sodium nitroprusside in severe heart failure. Am
J Cardiol 1980;45:331-6.
6. Pierpont G, Hale KA, Franciosa JA, Cohn IN. Effects of vasodilators
on pulmonary hemodynamics and gas exchange in left ventricular
failure. Am Heart J 1980;99:208-16.
7. Wildsmith JAW, Drummond GB, MacRae WR. Blood-gas changes
922 BENCOWITZ ET AL.
SODIUM NITROPRUSSIDE AND VENTILATION-PERFUSION MISMATCHING
lACC Vol. 4, No.5
November 1984:918-22
during induced hypotension with sodium nitroprusside, Br I Anaesth
1975;47:1205-10,
8, Casthe1y PA, Lear S, Cottrell IE. Lear E. Intrapulmonary shunting
during induced hypotension, Anesth Analg 1982;61:231-5.
9, Annest Sl, Gottlieb ME, Rhodes GR, et al. Nitroprusside and nitro-
glycerine in patients with posttraumatic pulmonary failure. I Trauma
1981;21:1029-31.
10, Colley PS. Cheney FW, Sodium nitroprusside increases Qs/Qt in dogs
with regional atelectasis, Anesthesiology 1977;47:338-41.
II. Pace JB. Pulmonary vascular response to sodium nitroprusside in
anesthetized dogs, Anesth Analg 1978;57:551-7.
12. Colley PS. Cheney FW. Hlastala MP, Ventilation-perfusion and gas
exchange effects of sodium nitroprusside in dogs with normal and
edematous lungs. Anesthesiology 1979;50:489-95.
13. Seltzer JL. Doto JB. Jacoby J. Decreased arterial oxygenation during
sodium nitroprusside administration for intraoperative hypertension.
Anesth Analg 1976;55:880-1.
14. Wagner PO, West JB. Ventilation-perfusion relationships. In: West
JB. ed. Pulmonary Gas Exchange. New York: Academic. 1980:219-62.
15. West JB, Wagner PD. Pulmonary gas exchange. In: West JB. ed,
Bioengineering Aspects of the Lung. New York: Marcel Dekker.
1977:361-455.
16. Styles M. Coleman AJ. Leary WP. Some hemodynamic effects of
sodium nitroprusside, Anesthesiology 1973;38:173-6.
17. Stone JG. Khambatta HJ. Matteo RS, Pulmonary shunting during
anesthesia with deliberate hypotension. Anesthesiology 1976;45:508-15.
18, Griffiths DPG. Cummins BH, Greenbaum R, et al. Cerebral blood
flow and metabolism during hypotension induced with sodium nitro-
prusside. Br J Anaesth 1974;46:671-9,
19. Braverman B. Ivankovich AD. Lavine LM. Klowden AJ. Failure of
cyanide to antagonize sodium nitroprusside in vivo in dogs. Anesth
Analg 1980;59:672-7.
20. Utsunomiya T. Krausz MM. Shepro D. Hechtman HB. Induction of
myocardial damage with nitroprusside. J Surg Res 1981;31:195-200.
21. Hodges MR. Stanley TH. Johansen RK. Pulmonary shunt and car-
diovascular responses to CPAP during nitroprusside-induced hypo-
tension, Anesthesiology 1977;46:339-41.
22, D'Oliveira M. Sykes MK. Chakrabarti MK. Orchard C, Keslin 1.
Depression of hypoxic pulmonary vasoconstriction by sodium nitro-
prusside and nitroglycerine. Br 1 Anaesth 1981;53:11-8,
23. Hoffman WE. Bergman S. Miletich OJ, Gans ar, Albrecht RF. Re-
gional vascular changes during hypotensive anesthesia. 1 Cardiovasc
Pharmacol 1982;4:310-4.
24. Hoffman WE. Satinover I. Miletich OJ, Albrecht RF. Gans Bl. Car-
diovascular changes during sodium nitroprusside or adenosine tri-
phosphate infusion in the rat. Anesth Analg 1982;61:99-103.
25. Rowe GG. Henderson RH. Systemic and coronary hemodynamic ef-
fects of sodium nitroprusside. Am Heart 1 1974;87:83-7.
26. Chatterjee K. Parmley WW. Ganz W. et al. Hemodynamic and met-
abolic responses to vasodilator therapy in acute myocardial infarction.
Circulation 1973;48:1183-93.
27. Fan FC. Kim S. Simchon S. Chen RYZ. Schuessler GB, Chien S.
Effects of sodium nitroprusside on systemic and regional hemody-
namics and oxygen utilization in the dog. Anesthesiology
1980;53:113-20.
28. Mentzer RM Jr, Nolan SP. Pulmonary vascular response to nitro-
prusside and dipyridamole. Surg Forum 1977;27:193-5.
29, Hill AB. Sykes MK. Reyes A. A hypoxic pulmonary vasoconstrictor
response in dogs during and after infusion of sodium nitroprusside.
Anesthesiology 1979;50:484-8.
30. Parsons GH. Leventhal IP, Hansen MM, Goldstein 10. Effect of
sodium nitroprusside on hypoxic pulmonary vasoconstriction in the
dog. 1 Appl Physiol 1981;51:288-92.
31. Breen PH, Schumacker PT. Hedenstierna G. Ali J, Wagner PO, Wood
LDH. How does increased cardiac output increase shunt in pulmonary
edema? 1 Appl Physiol 1982;53:1273-80.
32. Lynch IP. Mhyre JG. Dantzker DR. Influence of cardiac output on
intrapulmonary shunt. 1 Appl Physiol 1979;46:315-21.
